GeneSafe is a single gene NIPT that screens for a broad range of genetic disorders, including both inherited conditions and those caused by de novo mutations. By analysing cfDNA from a maternal blood sample, GeneSafe offers a more comprehensive risk assessment compared to traditional NIPT, covering conditions often missed in routine testing and allowing for early detection. Available in 3 panels: Inherited, De Novo, and Complete, GeneSafe is indicated for couples with advanced parental age, abnormal ultrasound findings, or those wishing to avoid invasive diagnostic procedures.
GeneSafe Inherited screens for common autosomal recessive genetic disorders, including cystic fibrosis, thalassemia-beta, sickle cell anaemia, and autosomal recessive deafness (types 1A and 1B).
GeneSafe De Novo detects 44 severe genetic disorders caused by de novo mutations in 25 genes. These mutations, which are associated with advanced paternal age, include skeletal dysplasia, congenital heart defects and neurodevelopmental disorders such as autism and intellectual disability.
GeneSafe Complete combines the Inherited and De Novo panels, providing a comprehensive genetic screen for couples seeking a thorough risk assessment during pregnancy.